Michael L. Curtin

The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex

Yupeng He, Sujatha Selvaraju, Michael L. Curtin et al. · Nature Chemical Biology · 2017 · 229 citations · Full text

Protein Function, Signal Transduction, Molecular Regulation +7

Thienopyrimidine Ureas as Novel and Potent Multitargeted Receptor Tyrosine Kinase Inhibitors

Yujia Dai, Yan Guo, Robin R. Frey et al. · Journal of Medicinal Chemistry · 2005 · 152 citations · Full text

Drug Target, Pharmacotherapy, Pharmaceutical Chemistry +17

Trifluoromethyl ketones as inhibitors of histone deacetylase

Robin R. Frey, Carol K. Wada, Robert B. Garland et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 147 citations · Full text

Histone Modifications, Chromatin, Medicinal Chemistry +10

Studies on the Synthesis of Nargenicin A₁:  Highly Stereoselective Synthesis of the Complete Carbon Framework via the Transannular Diels−Alder Reaction of an 18-Membered Macrolide

William Roush, Kazuo Koyama, Michael L. Curtin et al. · Journal of the American Chemical Society · 1996 · 118 citations

Highly Stereoselective Synthesis, Diversity Oriented Synthesis, 18-Membered Macrolide +15

Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC)

Michael L. Curtin, Robert B. Garland, H. Robin Heyman et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 113 citations · Full text

Medicinal Chemistry, Succinimide Hydroxamic Acids, Biochemistry +8